Latham Advises Astorg and Cinven on Acquisition of LGC

London team represents private equity consortium on the purchase of leading life science tools company.

November 25, 2019

A consortium jointly led by Astorg Partners (Astorg) and Cinven has announced that it has signed an agreement to acquire LGC, a global leader in the Life Sciences Tools sector.

LGC provides a comprehensive range of measurement tools, proficiency testing schemes, supply chain assurance standards, and specialty genomics reagents underpinned by leading analytical and measurement science capabilities. LGC is headquartered in the UK and serves almost 50,000 laboratories worldwide from its global office network, spanning 22 countries across five continents.

Latham & Watkins advised the consortium led by Astorg and Cinven on the transaction, with a deal team led by London partners Thomas Forschbach, Tom Evans, and Jay Sadanandan with associates Neil Campbell, Gillian Bourke, Suneel Basson-Bhatoa, James Freeland, and Ciara Faughnan-Moncrieff.

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.